| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―04 |
Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis |
Han Du, Zhongtao Du, Liang Wang, Hong Wang, Mingjun Jia, Chunge Zhang, Yun Liu, Cheng Zhang, Ya Zhang, Ruifeng Zhang, Shuang Zhang, Ning Zhang, Zhenghai Ma, Chen Chen, Wenjun Liu, Hui Zeng, George F. Gao, Xiaotong Hou, Yuhai Bi |
| 2 |
[GO] |
2023―Oct―19 |
Humoral and cellular immunity against diverse SARS-CoV-2 variants |
Changxu Chen, Xin Wang, Zeli Zhang |
| 3 |
[GO] |
2022―Dec―06 |
Infection of SARS-CoV-2 causes severe pathological changes in mouse testis |
Min Chen, Shihua Li, Shujun Liu, Yuhang Zhang, Xiuhong Cui, Limin Lv, Bowen Liu, Aihua Zheng, Qihui Wang, Shuguang Duo, Fei Gao |
| 4 |
[GO] |
2022―May―24 |
Pinpointing the animal origins of SARS-CoV-2: a genomic approach |
Shilei Zhao, Yali Hou, Xiaolong Zhang, Alice Hughes, Na Liu, Minsheng Peng, Qihui Wang, Yongbiao Xue, Hua Chen |
| 5 |
[GO] |
2021―Dec―24 |
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant |
Changshuo Wei, Ke-Jia Shan, Weiguang Wang, Shuya Zhang, Qing Huan, Wenfeng Qian |
| 6 |
[GO] |
2021―Nov―17 |
Alteration of the respiratory microbiome in COVID-19 patients with different severities |
Zhengtu Li, Yinhu Li, Linghua Li, Xiaoneng Mo, Shaoqiang Li, Mingzhou Xie, Yangqing Zhan, Ye Lin, Zhun Li, Min Xie, Zhaoming Chen, Airu Zhu, Ruosu Ying, Le Yu, Jincun Zhao, Shuai Cheng Li, Weiping Cai, Feng Ye |
| 7 |
[GO] |
2021―Aug―23 |
An efficient metatranscriptomic approach for capturing RNA virome and its application to SARS-CoV-2 |
Yao Meng, Liwen Xiao, Wenbing Chen, Fangqing Zhao, Xiang Zhao |
| 8 |
[GO] |
2021―May―29 |
Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19 |
Rong Xu, Pengcheng Liu, Tao Zhang, Qunfu Wu, Mei Zeng, Yingying Ma, Xia Jin, Jin Xu, Zhigang Zhang, Chiyu Zhang |
| 9 |
[GO] |
2021―Apr―21 |
The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development |
Rong Li, Jun Liu, Hui Zhang |
| 10 |
[GO] |
2021―Mar―18 |
COVID-19 mRNA vaccines |
Qingrui Huang, Jiawei Zeng, Jinghua Yan |
| 11 |
[GO] |
2021―Feb―21 |
Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene |
Paul D. Hartley, Richard L. Tillett, David P. AuCoin, Joel R. Sevinsky, Yanji Xu, Andrew Gorzalski, Mark Pandori, Erin Buttery, Holly Hansen, Michael A. Picker, Cyprian C. Rossetto, Subhash C. Verma |
| 12 |
[GO] |
2020―Nov―08 |
Dynamics of SARS-CoV-2 genome variants in the feces during convalescence |
Yi Xu, Lu Kang, Zijie Shen, Xufang Li, Weili Wu, Wentai Ma, Chunxiao Fang, Fengxia Yang, Xuan Jiang, Sitang Gong, Li Zhang, Mingkun Li |
| 13 |
[GO] |
2020―Mar―17 |
Porcine reproductive and respiratory syndrome virus (PRRSV) inhibition with engineered Cas13d |
Guo Li, Xinjie Wang, Yajing Liu, Xinyuan Lv, Guanglei Li, Chengcheng Zhao, Dandan Wang, Xingxu Huang, Xiaoxiang Hu |
| 14 |
[GO] |
2020―Feb―13 |
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines |
Xin Liu, Xiu-Jie Wang |
| 15 |
[GO] |
2020―Jan―30 |
Identification of potential cross-protective epitope between 2019-nCoV and SARS virus |
Tianyi Qiu, Tiantian Mao, Yuan Wang, Mengdi Zhou, Jingxuan Qiu, Jianwei Wang, Jianqing Xu, Zhiwei Cao |
|
